A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania
Author:
Affiliation:
1. Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Publisher
Mary Ann Liebert Inc
Subject
Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health
Link
http://www.liebertpub.com/doi/pdf/10.1089/cap.2016.0207
Reference42 articles.
1. AbbasAK, LichtmanAH, PillaiS: Cellular and Molecular Immunology (7th ed.). San Francisco, CA: Elsevier, 2012.
2. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial
3. Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled study
4. Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
5. Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lithium, the gold standard drug for bipolar disorder: analysis of current clinical studies;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-25
2. Promising immunomodulators for management of substance and alcohol use disorders;Expert Opinion on Pharmacotherapy;2024-05-02
3. Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review;Therapeutic Advances in Psychopharmacology;2024-01
4. Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder? A double-blind controlled clinical trial in Iran;International Clinical Psychopharmacology;2023-04-12
5. Cycloxoygenase-2 Inhibitors: A Novel Treatment Option for Borderline Personality Disorder?;Indian Journal of Psychological Medicine;2023-02-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3